These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11110048)

  • 1. Enhancement of lymphocyte proliferation induced by interleukin-12 and anti-interleukin-10 in HIV-infected patients during highly active antiretroviral therapy.
    Stylianou E; Aukrust P; Nordøy I; Müller F; Frøland SS
    APMIS; 2000 Sep; 108(9):601-7. PubMed ID: 11110048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
    Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming for high interferon-gamma production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients.
    Paganin C; Frank I; Trinchieri G
    J Clin Invest; 1995 Sep; 96(3):1677-82. PubMed ID: 7657839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death 1 receptor changes ex vivo in HIV-infected adults following initiation of highly active antiretroviral therapy.
    Spitsin S; Tustin NB; Riedel E; Tustin R; Murray JB; Peck LM; Khan M; Quinn J; Douglas SD
    Clin Vaccine Immunol; 2012 May; 19(5):752-6. PubMed ID: 22441393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell receptor excisional circles, telomere length, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppression.
    Aladdin H; Katzenstein T; Dreves AM; Ryder L; Gerstoft J; Skinhøj P; Pedersen BK; Ullum H
    Scand J Immunol; 2003 May; 57(5):485-92. PubMed ID: 12753506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.
    Byrnes AA; Harris DM; Atabani SF; Sabundayo BP; Langan SJ; Margolick JB; Karp CL
    J Leukoc Biol; 2008 Dec; 84(6):1447-53. PubMed ID: 18806124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: analysis of cellular immune responses.
    Blazevic V; Jankelevich S; Steinberg SM; Jacobsen F; Yarchoan R; Shearer GM
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):943-8. PubMed ID: 11527808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART.
    Martinez-Mariño B; Shiboski S; Hecht FM; Kahn JO; Levy JA
    AIDS; 2004 Oct; 18(15):1991-9. PubMed ID: 15577620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids rescue CD4+ T lymphocytes from activation-induced apoptosis triggered by HIV-1: implications for pathogenesis and therapy.
    Lu W; Salerno-Goncalves R; Yuan J; Sylvie D; Han DS; Andrieu JM
    AIDS; 1995 Jan; 9(1):35-42. PubMed ID: 7893439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
    Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
    Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2.
    Zanussi S; Simonelli C; Bortolin MT; D'Andrea M; Crepaldi C; Vaccher E; Nasti G; Politi D; Barzan L; Tirelli U; De Paoli P
    Clin Exp Immunol; 1999 Jun; 116(3):486-92. PubMed ID: 10361239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection.
    Vingerhoets J; Bisalinkumi E; Penne G; Colebunders R; Bosmans E; Kestens L; Vanham G
    Immunol Lett; 1998 Mar; 61(1):53-61. PubMed ID: 9562375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to superantigen stimulation in peripheral blood mononuclear cells from children perinatally infected with human immunodeficiency virus and receiving highly active antiretroviral therapy.
    McCloskey TW; Haridas V; Pontrelli L; Pahwa S
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):957-62. PubMed ID: 15358659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
    Tamarit A; Alberola J; Mir A; Benet I; Mira JV; Muñoz C; Galindo MJ; Navarro D
    J Clin Virol; 2004 Apr; 29(4):308-14. PubMed ID: 15018860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.
    Massanella M; Negredo E; Puig J; Puertas MC; Buzón MJ; Pérez-Álvarez N; Carrillo J; Clotet B; Martínez-Picado J; Blanco J
    AIDS; 2012 Nov; 26(18):2285-93. PubMed ID: 23018435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
    Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.
    Estaquier J; Idziorek T; Zou W; Emilie D; Farber CM; Bourez JM; Ameisen JC
    J Exp Med; 1995 Dec; 182(6):1759-67. PubMed ID: 7500020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.